Azercabtagene Zapreleucel

B-cell Mediated Autoimmune Disorders

TG Therapeutics, Inc.Phase 1

—

Rating in progress

Azercabtagene Zapreleucel in B-cell Mediated Autoimmune Disorders is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active